{"id":"https://openalex.org/W1940955610","doi":null,"title":"Solubility and stability enhancement of atorvastatin by cyclodextrin complexation.","display_name":"Solubility and stability enhancement of atorvastatin by cyclodextrin complexation.","publication_year":2009,"publication_date":"2009-05-01","ids":{"openalex":"https://openalex.org/W1940955610","mag":"1940955610","pmid":"https://pubmed.ncbi.nlm.nih.gov/20069794"},"language":"en","primary_location":{"id":"pmid:20069794","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20069794","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PDA journal of pharmaceutical science and technology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109276995","display_name":"Chinna Reddy Palem","orcid":"https://orcid.org/0009-0005-6125-1633","observed_orcids":["https://orcid.org/0009-0005-6125-1633"]},"institutions":[{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Chinna Reddy Palem","raw_affiliation_strings":["Department of Pharmaceutics, Bharati Vidyapeeth University, Poona College of Pharmacy, Erandwane, Pune, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Bharati Vidyapeeth University, Poona College of Pharmacy, Erandwane, Pune, Maharashtra, India","institution_ids":["https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102072072","display_name":"Shweta Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shweta Patel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088183107","display_name":"Varsha Pokharkar","orcid":"https://orcid.org/0000-0001-5464-9620","observed_orcids":["https://orcid.org/0000-0001-5464-9620","https://orcid.org/0000-0003-1185-0847","https://orcid.org/0000-0001-5438-0297"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Varsha B Pokharkar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3308,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.73985102,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"63","issue":"3","first_page":"217","last_page":"25"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atorvastatin-calcium","display_name":"atorvastatin calcium","score":0.9890000224113464},{"id":"https://openalex.org/keywords/beta-cyclodextrin","display_name":"\u03b2-cyclodextrin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/inclusion-complexes","display_name":"inclusion complexes","score":0.8069999814033508},{"id":"https://openalex.org/keywords/solubility-enhancement","display_name":"solubility enhancement","score":0.9200000166893005},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.847000002861023},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.9810000061988831},{"id":"https://openalex.org/keywords/freeze-drying","display_name":"freeze-drying","score":0.8100000023841858},{"id":"https://openalex.org/keywords/kneading","display_name":"kneading","score":0.7480000257492065},{"id":"https://openalex.org/keywords/co-evaporation","display_name":"co-evaporation","score":0.9620000123977661},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.7860000133514404},{"id":"https://openalex.org/keywords/tablet-formulation","display_name":"tablet formulation","score":0.5429999828338623},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.9369999766349792}],"concepts":[{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.9305883049964905},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.8991247415542603},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.677316427230835},{"id":"https://openalex.org/C39519442","wikidata":"https://www.wikidata.org/wiki/Q904893","display_name":"Differential scanning calorimetry","level":2,"score":0.649524986743927},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.5360003113746643},{"id":"https://openalex.org/C160892712","wikidata":"https://www.wikidata.org/wiki/Q901559","display_name":"Fourier transform infrared spectroscopy","level":2,"score":0.45556640625},{"id":"https://openalex.org/C2779433975","wikidata":"https://www.wikidata.org/wiki/Q40417805","display_name":"Cyclodextrin","level":2,"score":0.4161977767944336},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.35844188928604126},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.23587211966514587},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.21531948447227478},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002152","descriptor_name":"Calorimetry, Differential Scanning","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014961","descriptor_name":"X-Ray Diffraction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017550","descriptor_name":"Spectroscopy, Fourier Transform Infrared","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D047392","descriptor_name":"beta-Cyclodextrins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:20069794","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20069794","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PDA journal of pharmaceutical science and technology","raw_type":"Journal Article"},{"id":"mag:1940955610","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20069794","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2188241620","https://openalex.org/W2728060604","https://openalex.org/W2329770747","https://openalex.org/W1265182640","https://openalex.org/W7157064928","https://openalex.org/W4237220562","https://openalex.org/W2037367256","https://openalex.org/W3080949990","https://openalex.org/W2585375479","https://openalex.org/W2206404468"],"abstract_inverted_index":{"The":[0,35,146],"objective":[1],"of":[2,14,43,52,100,148,162],"the":[3,8,41,50,60,95,113,127,159],"study":[4],"was":[5,46,55,135,150],"to":[6,112],"increase":[7],"solubility,":[9],"stability,":[10,142],"and":[11,54,73,86,97,123,137,143,152],"dissolution":[12,98,124,144,160],"rate":[13,99],"atorvastatin":[15],"calcium":[16],"(ATN":[17],"Ca),":[18],"a":[19],"poorly":[20],"water-soluble":[21],"3-hydroxy":[22],"3-methyl":[23],"glutaryl":[24],"CoA":[25],"(HMG-CoA)":[26],"reductase":[27],"inhibitor":[28],"through":[29],"inclusion":[30,63],"complexation":[31,107],"with":[32,108,110],"beta-cyclodextrin":[33],"(beta-CD).":[34],"phase":[36],"solubility":[37,42,96,122],"profile":[38,161],"indicated":[39],"that":[40,94],"ATN":[44,101,130],"Ca":[45,102,131],"significantly":[47,104],"increased":[48],"in":[49,158],"presence":[51],"beta-CD":[53,109],"classified":[56],"as":[57],"AL-type,":[58],"indicating":[59],"1:1":[61],"stoichiometric":[62],"complexes.":[64,129],"Solid":[65],"complexes":[66],"prepared":[67],"by":[68,106],"physical":[69],"mixing,":[70],"kneading,":[71],"co-evaporation,":[72],"freeze-drying":[74],"methods":[75],"were":[76,103,156],"characterized":[77],"using":[78],"differential":[79],"scanning":[80],"calorimetry,":[81],"fourier":[82],"transform":[83],"infrared":[84],"spectroscopy,":[85],"powder":[87],"X-ray":[88],"diffractometry.":[89],"In":[90,116],"vitro":[91],"studies":[92],"showed":[93,120],"improved":[105],"respect":[111],"drug":[114],"alone.":[115],"contrast,":[117],"freeze-dried":[118],"product":[119],"higher":[121],"rates":[125],"than":[126],"other":[128],"unit":[132],"dosage":[133],"form":[134],"developed":[136],"evaluated":[138],"for":[139],"physico-chemical":[140],"properties,":[141],"rate.":[145],"stability":[147],"tablets":[149,163],"studied":[151],"no":[153],"significant":[154],"changes":[155],"detected":[157],"after":[164],"1":[165],"month.":[166]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}